Cediranib, an oral inhibitor of vascular endothelial growth factor receptor kinases, is an active drug in recurrent epithelial ovarian, fallopian tube, and peritoneal cancer (Q37474070)
Jump to navigation
Jump to search
scientific article published on 13 October 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Cediranib, an oral inhibitor of vascular endothelial growth factor receptor kinases, is an active drug in recurrent epithelial ovarian, fallopian tube, and peritoneal cancer |
scientific article published on 13 October 2009 |
Statements
1 reference
Cediranib, an oral inhibitor of vascular endothelial growth factor receptor kinases, is an active drug in recurrent epithelial ovarian, fallopian tube, and peritoneal cancer (English)
1 reference
Ursula A Matulonis
1 reference
Suzanne Berlin
1 reference
Percy Ivy
1 reference
Karin Tyburski
1 reference
Carolyn Krasner
1 reference
Corrine Zarwan
1 reference
Anna Berkenblit
1 reference
Susana Campos
1 reference
Neil Horowitz
1 reference
Stephen A Cannistra
1 reference
Hang Lee
1 reference
Julie Lee
1 reference
Maria Roche
1 reference
Margaret Hill
1 reference
Christin Whalen
1 reference
Laura Sullivan
1 reference
Chau Tran
1 reference
Benjamin D Humphreys
1 reference
Richard T Penson
1 reference
13 October 2009
1 reference
1 reference
5601-5606
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference